Stroke Trial, Recruiting NCT06786858 Sponsor: Medstar Health Research Institute Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06786858
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 21 years of age or older
  • People who had a stroke more than 6 months ago, confirmed by an MRI or CT scan
  • People who have at least some voluntary movement in the fingers of the affected hand (a score of 1 or more on the finger extension part of the Fugl-Meyer Test)
  • People who have adequate thinking and understanding abilities (confirm with trial site)
  • People who have difficulty fully opening their affected hand

Who may not be able to join:

  • People who have hemispatial neglect, which is a condition where someone has difficulty noticing things on one side of their body or surroundings (confirm with trial site)
  • People who have severe loss of sensation, as measured by a specific stroke assessment tool (the NIH Stroke Scale)
  • People who are currently taking or planning to take medications that reduce muscle stiffness or spasms during the study period
  • People who are unable to fully straighten or bend their finger joints passively (without using their own muscle strength)
  • People who are currently receiving physical therapy or occupational therapy outside of this study
  • People who have significant pain in any joint of the affected arm or hand that could make it difficult to take part in the study activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pete Lum, PhD, MedStar RI

Phone: 2028771464

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medstar Health Research Institute
Registry
ClinicalTrials.gov
Start date
4 January 2022
Est. completion
4 January 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fugl-Meyer Upper Extremity (FMA-UE) Test; Action Research Arm Test (ARAT); Motor Activity Log

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov